drugset / Trial / NCT01174992

A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair

NCT01174992

Phase 2/3 Completed 139 enrolled Ethicon, Inc. OMRIX Biopharmaceuticals · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

The objective of this study is to evaluate the safety and efficacy of EVICEL for use as an adjunct to dura sutures in elective cranial surgery to provide intraoperative watertight closure.

Timeline

Start
2010-07
Primary completion
2011-09
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic